SCHEMBL14459447

SCHEMBL14459447

O=S(=O)(Cc1ccc(Br)cc1F)c1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.61
PSEN2 P49810 1/20 0.61
APH1B Q8WW43 1/20 0.61
NCSTN Q92542 1/20 0.61
APH1A Q96BI3 1/20 0.61
PSENEN Q9NZ42 1/20 0.61
AKR1B1 P15121 1/20 0.51
FLT1 P17948 3/20 0.49
FLT4 P35916 3/20 0.49
KDR P35968 3/20 0.49
SOD1 P00441 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
GRK2 P25098 1/20 0.42
RECQL P46063 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KMT2A Q03164 5/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13676607 0.78 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7221320 0.77 AKR1B1 (0.51) AKR1B1FLT1FLT4KDRCHRM5
SCHEMBL1062719 0.76 PSEN1 (1.00) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL25308662 0.74 AKR1B1 (0.51) AKR1B1CHRM5
SCHEMBL30797087 0.74 AKR1B1 (0.51) AKR1B1KMT2ACHRM5
SCHEMBL12982381 0.74 AKR1B1 (0.51) AKR1B1KMT2ACHRM5
SCHEMBL11703167 0.74 AKR1B1 (0.51) AKR1B1SMN1; SMN2GRK2RECQLCTDSP1
SCHEMBL3526496 0.73 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1364668 0.72 PSEN1 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL4820867 0.72 PSEN1 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1815860-A2 Phosphate transport inhibitors GENZYME CORPORATION (US) 2007-08-08 EP disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed
US-20070021509-A1 Phosphate transport inhibitors JOZEFIAK THOMAS H 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070021509-A1 Phosphate transport inhibitors SLC34A2, SLC34A1, SLC20A1 PSEN1 2217/4885PSEN2 2328/4885APH1B 3021/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.